Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Esther, Scheerman"'
Autor:
Esther Scheerman, Carolien H.M. van Deurzen, Agnes Jager, Philipp Harter, Dimo Dietrich, Ewald van Dijk, Sandra Schmidt, Philip C. Schouten, Esther H. Lips, Stefan Kommoss, Roelof J.C. Kluin, Rita K. Schmutzler, Petra M. Nederlof, Lodewyk F. A. Wessels, Patricia C. Ewing-Graham, Daniel J. Vis, Frederik Marmé, Andreas du Bois, Jan Hauke, Nikolaus de Gregorio, Sabine C. Linn, Alexander Burges, Corinna Ernst, Lisa Richters, Katharina Prieske, Eric Hahnen
Publikováno v:
Clinical Cancer Research, 27(23), 6559-6569. American Association for Cancer Research Inc.
Clinical Cancer Research, 27(23)
Clinical Cancer Research, 27(23)
Purpose: Previously, we developed breast cancer BRCA1-like and BRCA2-like copy-number profile shrunken centroid classifiers predictive for mutation status and response to therapy, targeting homologous recombination deficiency (HRD). Therefore, we inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f92748eeb27c5de29c2a3cf5c927e2
https://pure.eur.nl/en/publications/b119872f-aea2-46e5-ae94-0a8a60a46639
https://pure.eur.nl/en/publications/b119872f-aea2-46e5-ae94-0a8a60a46639
Autor:
Philip C, Schouten, Lisa, Richters, Daniel J, Vis, Stefan, Kommoss, Ewald, van Dijk, Corinna, Ernst, Roelof J C, Kluin, Frederik, Marmé, Esther H, Lips, Sandra, Schmidt, Esther, Scheerman, Katharina, Prieske, Carolien H M, van Deurzen, Alexander, Burges, Patricia C, Ewing-Graham, Dimo, Dietrich, Agnes, Jager, Nikolaus, de Gregorio, Jan, Hauke, Andreas, du Bois, Petra M, Nederlof, Lodewyk F, Wessels, Eric, Hahnen, Philipp, Harter, Sabine C, Linn, Rita K, Schmutzler
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(23)
Previously, we developed breast cancerThe detection rate of theThe newly trained classifiers detected most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80471f361c32c97d5fe4a66d0101b2b4
https://pubmed.ncbi.nlm.nih.gov/34593530
https://pubmed.ncbi.nlm.nih.gov/34593530
Autor:
Rashmie D. Debipersad, Gabe S. Sonke, Lennart Mulder, Esther H. Lips, Esther Scheerman, L. E. van der Kolk, J Wessling, Fbl Hogervorst, Petra M. Nederlof
Publikováno v:
Cancer Research. 77:P4-12
Background As estrogen receptor (ER)-positive breast cancer in BRCA1 mutation carriers arises at an older age with less aggressive tumor characteristics than ER negative BRCA1 mutated breast cancer, it has been suggested that these tumors are 'sporad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83d50411c0e41e6ecf0fcaf0261285a9
https://doi.org/10.1158/1538-7445.sabcs16-p4-12-03
https://doi.org/10.1158/1538-7445.sabcs16-p4-12-03
Autor:
Esther Scheerman, Esther H. Lips, Rashmie D. Debipersad, Lizet E. van der Kolk, Lennart Mulder, Petra M. Nederlof, Jelle Wesseling, Frans B. L. Hogervorst
Publikováno v:
Molecular Cancer Research. 14:A27-A27
Background: Most breast cancers arising in BRCA1-mutation carriers are triple negative (TN). Therefore, it has been suggested that TN status is intrinsic to BRCA1-mutated tumors. However, 10 to 20% of BRCA1-associated breast cancers are estrogen rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce3044d3516019afe6422424ed6e777a
https://doi.org/10.1158/1557-3125.advbc15-a27
https://doi.org/10.1158/1557-3125.advbc15-a27